C00165 (Diacylglycerol)	673,504,4
C05981 (Phosphatidylinositol-3,4,5-trisphosphate)	582,378,4
D07907 (Erlotinib (INN))	386,249,4
D01977 (Gefitinib (JAN/USAN/INN))	386,230,4
2065 (ERBB3)	230,406,276,423
2064 (ERBB2)	230,389,276,406
1956 (EGFR)	230,244,276,261
2932 (GSK3B)	716,389,762,406
1978 (EIF4EBP1)	807,315,853,332
6198 (RPS6KB1)	807,287,853,304
6199 (RPS6KB2)	807,287,853,304
2475 (MTOR)	716,302,762,319
2064 (ERBB2)	230,261,276,278
572 (BAD)	716,353,762,370
2549 (GAB1)	424,402,470,419
7039 (TGFA)	132,262,178,279
2065 (ERBB3)	230,472,276,489
6654 (SOS1)	629,589,675,606
6655 (SOS2)	629,589,675,606
2885 (GRB2)	549,589,595,606
25759 (SHC2)	477,589,523,606
399694 (SHC4)	477,589,523,606
53358 (SHC3)	477,589,523,606
6464 (SHC1)	477,589,523,606
5578 (PRKCA)	751,496,797,513
5579 (PRKCB)	751,496,797,513
5582 (PRKCG)	751,496,797,513
5335 (PLCG1)	550,496,596,513
5336 (PLCG2)	550,496,596,513
5290 (PIK3CA)	496,370,542,387
5291 (PIK3CB)	496,370,542,387
5293 (PIK3CD)	496,370,542,387
5295 (PIK3R1)	496,370,542,387
5296 (PIK3R2)	496,370,542,387
8503 (PIK3R3)	496,370,542,387
10000 (AKT3)	627,370,673,387
207 (AKT1)	627,370,673,387
208 (AKT2)	627,370,673,387
1956 (EGFR)	230,203,276,220
1950 (EGF)	132,238,178,255
5594 (MAPK1)	918,589,964,606
5595 (MAPK3)	918,589,964,606
5604 (MAP2K1)	845,589,891,606
5605 (MAP2K2)	845,589,891,606
369 (ARAF)	773,589,819,606
5894 (RAF1)	773,589,819,606
673 (BRAF)	773,589,819,606
3265 (HRAS)	702,589,748,606
3845 (KRAS)	702,589,748,606
4893 (NRAS)	702,589,748,606
5728 (PTEN)	598,307,644,324
4763 (NF1)	607,629,653,646
4233 (MET)	230,521,276,538
3480 (IGF1R)	230,565,276,582
5156 (PDGFRA)	230,708,276,725
5159 (PDGFRB)	230,708,276,725
3791 (KDR)	230,651,276,668
1956 (EGFR)	230,604,276,621
3082 (HGF)	132,521,178,538
2261 (FGFR3)	230,764,276,781
2263 (FGFR2)	230,764,276,781
6774 (STAT3)	691,154,737,171
3716 (JAK1)	541,154,587,171
3717 (JAK2)	541,154,587,171
596 (BCL2)	733,756,779,773
581 (BAX)	795,676,841,693
598 (BCL2L1)	733,733,779,750
10018 (BCL2L11)	629,743,675,760
3479 (IGF1)	132,565,178,582
7422 (VEGFA)	132,651,178,668
5154 (PDGFA)	132,708,178,725
5155 (PDGFB)	132,708,178,725
56034 (PDGFC)	132,708,178,725
80310 (PDGFD)	132,708,178,725
2247 (FGF2)	132,764,178,781
6714 (SRC)	541,192,587,209
6774 (STAT3)	691,192,737,209
2621 (GAS6)	132,815,178,832
558 (AXL)	230,815,276,832
3569 (IL6)	132,863,178,880
3570 (IL6R)	230,863,276,880
6194 (RPS6)	890,287,936,304
1977 (EIF4E)	890,315,936,332
253314 (EIF4E1B)	890,315,936,332
9470 (EIF4E2)	890,315,936,332
2309 (FOXO3)	716,427,762,444
10018 (BCL2L11)	1127,427,1173,444
7039 (TGFA)	132,604,178,621
1956 (EGFR)	230,289,276,306
2065 (ERBB3)	230,306,276,323
3084 (NRG1)	132,339,178,356
9542 (NRG2)	132,339,178,356
4233 (MET)	230,455,276,472
hsa05223: Non-small cell lung cancer	292,100,394,134
hsa05212: Pancreatic cancer	405,100,507,134
hsa04150: mTOR signaling pathway	820,246,922,280
hsa04010: MAPK signaling pathway	825,548,927,582
hsa01521: EGFR tyrosine kinase inhibitor resistance	40,45,422,70
hsa04151: PI3K-Akt signaling pathway	534,412,636,446
hsa04012: ErbB signaling pathway	111,133,213,167
hsa04210: Apoptosis	822,725,914,750
hsa05214: Glioma	519,105,621,130
hsa04630: JAK-STAT signaling pathway	583,216,705,250
